Macroaxis: Personalized Investing
Simple Personalized Investing

SP 500   1,655   13.81  Index Moved Down -0.83%
JNJ PFE NVS SNY Cigarettes Recreation Marketing Copper 
United States GSPC USD ...  |  Macroaxis Daily Picks


Processing
Collecting data for AEGR

Aegerion news

 
 Companies |  Insiders  | Dashboard  
  
Add To Portfolio  add AEGR to portfolio
   

Aegerion Pharmaceuticals

Stock@NASDAQ 
United States USD
     
Use Aegerion Pharmaceuticals Inc news within your existing portfolios mixed with equities fromn NASDAQ to protect against small markets fluctuations as well as to determine Stock diversification method that is right for you.  Build Portfolio
View Aegerion Timeline

    
  
One day ago at www.sbwire.com         
PERFORMING BIOTECHNOLOGY and DRUGS COMPANIES Aegerion ...
Huntington Beach CA 05212013 PSPicks.com provides its subscribers with a free newsletter that reports up to the minute information and exclusive charts on cheap undervalued hidden and undiscovered stocks traded on the NASDAQ ...
Check History
Focus
  
  
Few days ago at www.usmarketsdaily.com         
Aegerion Pharmaceuticls Inc.a shares down by 1.56
Northern WI 05172013 The prices of Aegerion Pharmaceuticals Inc. currently trading at 60.74 down by 1.56. Aegerion Pharmaceuticals PT Raised to 85.00 at Deutsche Bank Mideast Time Stocks With Positive Momentum Aegerion Pharmaceuticals Inc.
Check History
Focus
  
  
Few days ago at www.techsonian.com         
Bullish Movements in Focus Aegerion Pharmaceuticals Inc. NASDAQAEGR ...
Techsonian May 17 2013 NEW YORK May 17 2013 FastMovingStock.com is engaged in providing valuable ideas and news information on U.S. stocks on a regular basis.
Check History
Focus
  
  
Few days ago at zolmax.com         
Aegerion Pharmaceuticals PT Raised to 65.00 at Leerink Swann
Zolmax May 16 2013 Separately analysts at Jefferies Group raised their price target on shares of Aegerion Pharmaceuticals from 46.00 to 50.00 in a research note to investors on Friday May 10th.
Check History
Focus
  
  
Few days ago at www.mideasttime.com         
Aegerion Pharmaceuticals PT Raised to 85.00 at Deutsche Bank
Analysts at Jefferies Group raised their price target on shares of Aegerion Pharmaceuticals from 46.00 to 50.00 in a research note to investors on Friday May 10th. Market News Tesla Motors Cisco Infinity Pharma Aegerion Kohl ValueWalk ValueWalk
Check History
Focus
  
  
Few days ago at www.benzinga.com         
MidAfternoon Market Update Optimer Falls as Halozyme Rockets Upwards
Aegerion Pharmaceuticals Inc got a boost shooting up 34.71 percent to 63.32. Aegerion Pharmaceutical five year expected PEG ratio is 0.29.
Check History
Focus
  
  
Few days ago at www.sbwire.com         
MidDay Market Movers Aegerion Pharmaceuticals Inc. Cisco Systems Inc ...
Huntington Beach CA 05162013 PSPicks.com provides its subscribers with a free newsletter that reports up to the minute information and exclusive charts on cheap undervalued hidden and undiscovered stocks traded on the NASDAQ ...
Check History
Focus
  
  
Few days ago at www.mideasttime.com         
Aegerion Pharmaceuticals Price Target Raised to 50.00 at Jefferies Group ...
Analysts at Needham and Company raised their price target on shares of Aegerion Pharmaceuticals from 36.00 to 50.00 in a research note to investors on Thursday May 2nd. Large Spread Trades in AEGR The Options Insider How one bull is staying in Aegerion optionMONSTER Research
Check History
Focus
  
  
Few days ago at www.dailypolitical.com         
Aegerion Pharmaceuticals Price Target Increased to 50.00 by Analysts at ...
Daily Political May 10 2013 Analysts at Needham and Company raised their price target on shares of Aegerion Pharmaceuticals from 36.00 to 50.00 in a research note to investors on Thursday May 2nd. Jefferies More Bullish on Aegerion Pharmaceuticals Following ... StreetInsider.com
Check History
Focus
  
  
Few days ago at www.mideasttime.com         
Aegerion Pharmaceuticals Price Target Raised to 50.00 at Needham ...
Aegerion Pharmaceuticals logo Aegerion Pharmaceuticals had its target price boosted by Needham and Company from 36.00 to 50.00 in a report issued on Thursday Analyst Ratings.Net reports. They currently have a buy rating on the ...
Check History
Focus
  
  
Few days ago at www.complianceweek.com         
Aegerion Pharmaceuticals Appoints New Board Member
Compliance Week May 6 2013 Biopharmaceutical company Aegerion Pharmaceuticals has appointed Anne VanLent to its board of directors effective as of April 26.
Check History
Focus
  
  
Few days ago at www.dailypolitical.com         
Aegerion Pharmaceuticals Price Target Raised to 65.00 at Lazard Capital ...
Aegerion Pharmaceuticals has a one year low of 12.27 and a one year high of 42.22. The stock 50day moving average is currently 38.45.
Check History
Focus
  
  
Few days ago at www.nasdaq.com         
Loss at Aegerion Narrower Than Expected Analyst Blog NASDAQ.com
NASDAQ May 3 2013 Aegerion Pharmaceuticals Inc. reported first quarter 2013 net loss per share of 64 cents narrower than the Zacks Consensus Estimate of a loss of 72 cents but wider than the yearago loss of 51 cents.
Check History
Focus
  
  
Few days ago at www.4-traders.com         
AEGERION PHARMACEUTICALS INC. Aegerion Pharmaceuticals Grants ...
CAMBRIDGE Mass. May 3 2013 Aegerion Pharmaceuticals Inc. a biopharmaceutical company dedicated to the development and commercialization of innovative lifealtering therapies for patients with debilitating ... Aegerion Pharmaceuticals Announces Presentation at the Bank of America ... Wall Street Journal
Check History
Focus
  
  
Few days ago at www.globenewswire.com         
Aegerion Pharmaceuticals Announces Presentation at the Bank of America ...
GlobeNewswire May 3 2013 CAMBRIDGE Mass. May 3 2013 Aegerion Pharmaceuticals Inc. an emerging biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat debilitating and often fatal ...
Check History
Focus
  
    

Aegerion Revenue

Aegerion Pharmaceuticals Inc is rated below average in revenue category among related companies. Market size based on revenue of Drug Manufacturers - Major industry is presently estimated at about 386.33 Billion. Aegerion adds roughly 1.23 Million in revenue claiming only tiny portion of equities under Drug Manufacturers - Major industry.
Embed  Financial Widgets Catalog
Export  Financial Widgets Catalog

Aegerion Research Report

   
Generate Report

Aegerion vs. Johnson

Correlation analysis and fundamentals comparison between Aegerion Pharmaceuticals and Johnson Johnson
Correlation
Fundamentals

Aegerion Total Debt

Based on latest financial disclosure Aegerion Pharmaceuticals Inc has Total Debt of 10.27 M. This is 99.32% lower than that of Healthcare sector, and 99.84% lower than that of Drug Manufacturers - Major industry, The Total Debt for all stocks is 99.8% higher than the company.
Embed  Financial Widgets Catalog
Export  Financial Widgets Catalog
In most industries, total debt may also include current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meaningful to compare total debt amounts between companies that operate within the same sector.
More...
Follow Aegerion News with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
Get Widget
 
Add Aegerion to your reader
Syndicate
 
 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
Take our survey
  
Financial Widget
Financial Widgets
Financial Content
Investing Content
Get Stock Ticker
Stock Tickers
 
Opportunities   Themes   Suggestions
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
  © 2013 Macroaxis Inc. All rights reserved       Custom Reporting   Advertising   Mobile Access   Retirement Grader   Alpha Search   Compare Stocks
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium